153 related articles for article (PubMed ID: 8989266)
1. Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1.
Yamada S; Yoshimoto K; Sano T; Takada K; Itakura M; Usui M; Teramoto A
J Clin Endocrinol Metab; 1997 Jan; 82(1):239-42. PubMed ID: 8989266
[TBL] [Abstract][Full Text] [Related]
2. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.
Gadelha MR; Prezant TR; Une KN; Glick RP; Moskal SF; Vaisman M; Melmed S; Kineman RD; Frohman LA
J Clin Endocrinol Metab; 1999 Jan; 84(1):249-56. PubMed ID: 9920092
[TBL] [Abstract][Full Text] [Related]
4. [Familial pituitary tumors].
Yoshimoto K; Saito S
Nihon Rinsho; 1995 Nov; 53(11):2691-6. PubMed ID: 8538028
[TBL] [Abstract][Full Text] [Related]
5. Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12.
Gadelha MR; Une KN; Rohde K; Vaisman M; Kineman RD; Frohman LA
J Clin Endocrinol Metab; 2000 Feb; 85(2):707-14. PubMed ID: 10690880
[TBL] [Abstract][Full Text] [Related]
6. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
[TBL] [Abstract][Full Text] [Related]
7. A possible tumor suppressor gene for parathyroid adenomas.
Iwasaki H
Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
Dong Q; Debelenko LV; Chandrasekharappa SC; Emmert-Buck MR; Zhuang Z; Guru SC; Manickam P; Skarulis M; Lubensky IA; Liotta LA; Collins FS; Marx SJ; Spiegel AM
J Clin Endocrinol Metab; 1997 May; 82(5):1416-20. PubMed ID: 9141526
[TBL] [Abstract][Full Text] [Related]
9. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
10. Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.
Kjellman M; Roshani L; Teh BT; Kallioniemi OP; Höög A; Gray S; Farnebo LO; Holst M; Bäckdahl M; Larsson C
J Clin Endocrinol Metab; 1999 Feb; 84(2):730-5. PubMed ID: 10022445
[TBL] [Abstract][Full Text] [Related]
11. Gigantism in sibling unrelated to multiple endocrine neoplasia: case report.
Matsuno A; Teramoto A; Yamada S; Kitanaka S; Tanaka T; Sanno N; Osamura RY; Kirino T
Neurosurgery; 1994 Nov; 35(5):952-5; discussion 955-6. PubMed ID: 7838348
[TBL] [Abstract][Full Text] [Related]
12. Isolated familial somatotropinomas: clinical and genetic considerations.
Frohman LA
Trans Am Clin Climatol Assoc; 2003; 114():165-77. PubMed ID: 12813918
[TBL] [Abstract][Full Text] [Related]
13. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
Evans CO; Brown MR; Parks JS; Oyesiku NM
J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
[TBL] [Abstract][Full Text] [Related]
14. Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas.
Soares BS; Eguchi K; Frohman LA
J Clin Endocrinol Metab; 2005 Dec; 90(12):6580-7. PubMed ID: 16189251
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas.
Asteria C; Anagni M; Persani L; Beck-Peccoz P
J Endocrinol Invest; 2001 Nov; 24(10):796-801. PubMed ID: 11765049
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
18. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus.
Eubanks PJ; Sawicki MP; Samara GJ; Wan YJ; Gatti RA; Hurwitz M; Passaro E
Am J Surg; 1997 Jun; 173(6):518-20. PubMed ID: 9207166
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
